1)日本腎臓学会(編):エビデンスに基づくCKD診療ガイドライン2018, 東京医学社, 2018
2)Levey AS, et al:The definition, classification, and prognosis of chronic kidney disease;A KDIGO Controversies Conference report. Kidney Int 80:17-28, 2011
3)Sarnak MJ, et al:Kidney disease as a risk factor for development of cardiovascular disease;A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154-2169, 2003
4)Go AS, et al:Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296-1305, 2004
5)Donabedian A:The quality of care;How can it be assessed? JAMA 260:1743-1748, 1988
6)Tu K, et al:Quality indicators for the detection and management of chronic kidney disease in primary care in Canada derived from a modified Delphi panel approach. CMAJ Open 5:E74-E81, 2017
7)Van den Bulck SA, et al:Developing quality indicators for chronic kidney disease in primary care, extractable from the electronic medical record. A Rand-modified Delphi method. BMC Nephrol 21:161, 2020
8)Fukuma S, et al:Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data;A RAND-modified Delphi method. Clin Exp Nephrol 21:247-256, 2017
9)要 伸也:腎臓病療養指導士制度とチーム医療,日腎会誌 60:1-5, 2018
10)山縣邦弘,他:CKDステージG3b〜5診療ガイドライン2017(2015追補版).日腎会誌59:1093-1216, 2017
11)Couser WG, et al:The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80:1258-1270, 2011